Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05369533 · ClinicalTrials.gov registry record · Phase 1

Dopaminergic Enhancement of Rehabilitation Therapy Early After Stroke

A Phase 1 study of Stroke, sponsored by University of California, Los Angeles.

Completed
Registry status
Phase 1
Development phase
25
Enrollment target
1
Study location

NCT05369533 is a Phase 1 study of Stroke that has completed, run by University of California, Los Angeles. The registered enrollment target is 25 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05369533, a Phase 1 study of Stroke, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
Phase 1
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

This study explores the effects of telerehabilitation and a study medication on rehabilitation outcomes in patients with stroke resulting in arm weakness. Patients with arm weakness due to a stroke that happened in the past 30 days will be randomized into one of three groups: \[1\] TR and placebo (a sugar pill) on top of usual care; \[2\] TR and a medication (Sinemet 25/100) on top of usual care; \[3\] or usual care alone (no TR and no pill, but people in this group will be offered TR once the study is done). TR consists of 70 minutes/day of activities targeting arm function, 6 days a week for 6 weeks.

Conditions Studied

Stroke

Interventions

  • DRUG Placebo
  • DEVICE Telerehabilitation
  • DRUG Sinemet Pill

Study Locations (1)

California

  • California Rehabilitation Institute - Los Angeles

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2022-08-01
Est. Completion 2024-03-11
Phase Phase 1

Sponsor

University of California, Los Angeles

897 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05369533

The ClinicalTrials.gov registry entry for NCT05369533 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT05369533 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05369533 about?

NCT05369533 is a clinical study titled "Dopaminergic Enhancement of Rehabilitation Therapy Early After Stroke". This study explores the effects of telerehabilitation and a study medication on rehabilitation outcomes in patients with stroke resulting in arm weakness. Patients with arm weakness due to a stroke that happened in the past 30 days will be randomized into one of three groups: \[1\] TR and placebo (a...

What is the current status of trial NCT05369533?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2022-08-01. Estimated completion is 2024-03-11.

What conditions does trial NCT05369533 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT05369533?

The interventions under investigation include: Placebo (DRUG), Telerehabilitation (DEVICE), Sinemet Pill (DRUG).

Who is sponsoring clinical trial NCT05369533?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05369533 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Stroke

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.